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Abstract 
Objectives The occurrence of cardiac iron deposition is one of the late effect of iron over load which 
causes cardiovascular disease (CVD) in patients who are affected by beta-thalassemia major. Evaluation 
of some cardiovascular risk factors plays a crucial role in prediction and prevention of CVD. Subjects and 
methods This study consisted of 70 young adult subjects with beta-thalassemia major (beta-TM) (aged 
<30 years) and 71 age- and sex-matched healthy subjects as control group in the range of 20-30 years. 
Hematological and biochemical laboratory parameters including apolipoprotein (Apo)A1 and ApoB, 
oxidative stress biomarker pro-oxidant-antioxidant balance (PAB), homocysteine, serum high-sensitivity 
C-reactive protein (hs-CRP), and lipid profile were evaluated. Results ApoA1, ApoB, lipid profiles, and 
homocysteine were significantly decreased in patients group (P < 0.001); however, very low-density 
lipoprotein and also mean corpuscular hemoglobin concentration (P > 0.05) were different. Some 
elements included ferritin (P < 0.001), PAB (P < 0.001), and ApoB/apoA1 ratio (P < 0.05) statistically 
increased in patients, whereas hs-CRP (P > 0.05) was not significantly different in study groups. 
Exception of high-density lipoprotein (P > 0.05), other lipid profiles, and apoB had a negative meaningful 
correlation with PAB (P < 0.05). Likewise, apoA1, apoB, apoB/A1 ratio with apoB and homocysteine 
showed a strong correlation (P < 0.05). We did not find a slight correlation between apoB/A1 ratio in the 
company of oxidative stress marker PAB (r = -0.366; P = 0.086). We found a statistical correlation 
between apoB/A1 and homocysteine (P < 0.05). Discussion Higher level of some risk factors like PAB 
values, apoB/A1 ratio concentration, and lipid profiles is able to involve in the prognostic pathological 
consequences in patients with beta-thalassemia major. Even so, they contribute toward the gradual 
development of CVD. 
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